FINWIRES · TerminalLIVE
FINWIRES

National Bank of Canada Boosts Agnico Eagle Mines' Price Target; Outperform Rating Maintained

By

-- National Bank of Canada on Friday raised its price target on the shares of Agnico Eagle Mines (AEM.TO) from $345 to $350 while its outperform rating was maintained following the company's first-quarter results.

The analysts said they continue to expect production growth of 4.3-million ounces by 2034, supported by upcoming technical reports for Hope Bay and San Nicolas, an update on Canadian Malartic expansion plans in Q3, and expected approvals for Detour Lake underground and Upper Beaver in 2027.

They added that their growth estimates could increase further with recent acquisitions in Finland, which may help build a roughly 500,000-ounce production hub over the next decade.

Agnico ended Q1 with US$2.91 billion in net cash and plans to expand its share buyback program to US$2 billion. With a strong balance sheet, the company aims to keep returning cash to shareholders while also speeding up development of its organic growth projects, which should provide additional catalysts throughout the year, the analysts said.

"We updated our estimates to incorporate Agnico Eagle's reported Q1 financial and operating results, including adjusted EBITDA of US$3.01 billion and adjusted EPS of US$3.41/share. Financial Results were above NBCM Estimate due to higher sales/revenue and lower exploration costs," the analysts said.

Price: $249.58, Change: $-5.86, Percent Change: -2.29%

Related Articles

Research

Research Alert: CFRA Lowers View On Bio-rad Laboratories To Sell From Hold

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month price target by $45 to $235, reflecting a 25.6x multiple of our 2026 EPS estimate (down to $9.17 from $10.15; we cut our 2027 EPS estimate to $9.97 from $10.68), a discount to BIO's three-year historical forward average of 29.5x. Rather than a dramatic cut to National Institutes of Health (NIH) funding, Congress approved a modest increase for 2026 funding, helping reduce research budget concerns that loomed during 2025. However, BIO and peers anticipate that research spending growth from academic and early-stage biotech could remain muted over the near term as academic institutions adjust. The outlook for 2026 anticipates ongoing pressure, with BIO cutting sales and margin expectations during the Q1 earnings report, citing headwinds arising from the U.S.-Iran conflict in the Middle East such as weaker diagnostics sales and higher freight and fuel costs.

$BIO
Insider Trading

Comfort Systems USA Insider Sold Shares Worth $889,890, According to a Recent SEC Filing

Pablo G. Mercado, Director, on April 30, 2026, sold 500 shares in Comfort Systems USA (FIX) for $889,890. Following the Form 4 filing with the SEC, Mercado has control over a total of 3,000 common shares of the company, with 3,000 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1035983/000153524626000004/xslF345X05/form4-05012026_040501.xml

$FIX
Insider Trading

Kaiser Aluminum Insider Sold Shares Worth $524,757, According to a Recent SEC Filing

Keith Harvey, Director, President & CEO, on April 29, 2026, sold 3,031 shares in Kaiser Aluminum (KALU) for $524,757. Following the Form 4 filing with the SEC, Harvey has control over a total of 94,308 common shares of the company, with 94,308 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/811596/000119312526201545/xslF345X05/ownership.xml

$KALU